Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Technology

Kim Mi-hyung, CEO of ANTEROGEN CO., LTD.: “Beyond Pain Relief to Cartilage Regeneration… We Saw Potential in Injectable Formulations”

“This is significant because regeneration of the meniscus was observed following the injection. The results strongly suggest the possibility of structural improvement beyond mere pain relief.”Lee Seon…
  • 2026-10-21 07:02:02
  • NA EUN-KYUNG
Technology

After a 10-Year Wait, Cha Healthcare’s IPO Obligations Have Been Lifted… Recovery Burden Falls on Parent Company [Cha Bio Deep Seek ①]

Chabiotech Co.,Ltd.(085660)has removed the “2027 initial public offering (IPO)” obligation that had been tied to its key subsidiary, Cha Healthcare. In the process of restructuring its existing financ…
  • 2026-10-21 07:01:02
  • KIM SAE-MI
Technology

“Treating Hives Instead of Red Bull”… A Japanese Doctor’s Perspective on ‘Omliclo’s’ Competitive Edge [WAC 2026]

Associate Professor Korekazu Hayama of Nihon University’s School of Medicine was interviewed on the 16th at the World Allergy Congress (WAC 2026) held in Kyoto, Japan. (Photo: ReporterKIM SAE-MI ) …
  • 2026-10-20 08:02:02
  • KIM SAE-MI
Technology

Park Hyun-sook, CEO of CellBio: “Beyond Phase 2 Trials in Korea, Preparing for Clinical Trials in Japan… Discussing Joint Development with Partners” [BioJapan 2026]

Park Hyun-sook, CEO of CellBio, is being interviewed by E-Daily at “Bio Japan 2026,” which was recently held in Yokohama, Japan. (Photo: Reporter Minji Son ) “The key outcome we hope to achieve at…
  • 2026-10-20 07:06:02
  • Minji Son
Technology

[SkyLabs in Depth ③] 52% of Revenue from Overseas… Expanding Global Market with 'Continuous Blood Pressure Monitoring'

“SkyLabs is not a company that will expand overseas in the future—it is a company that is already growing overseas.”CEO Lee Byung-hwan made this remark at a press conference prior to the company’s IPO…
  • 2026-10-20 07:01:06
  • Kim Seung-kwon
Technology

[In-Depth Look at SkyLabs ②] The "Holy Grail of Medical Devices": The Cuffless Blood Pressure Monitor… Proven by Its Accuracy

There are two technologies in the medical device industry that are referred to as the “Holy Grail”: non-invasive blood glucose monitors that do not require blood sampling, and cuffless blood pressure …
  • 2026-10-20 07:01:06
  • Kim Seung-kwon
Technology

[In-Depth Look at SkyLabs ①] Why Did a 5G Engineer Create a 'Ring'?

“Communication technology is, at its core, signal processing technology. It is used in exactly the same way to process biological signals.”Lee Byung-hwan, CEO of SkyLabs, explained the origins of the …
  • 2026-10-20 07:01:02
  • Kim Seung-kwon
Technology

[Exclusive] From Partnership to Competition… Global Company’s New Product Allegedly Misappropriates Curiox Technology

Waters (formerly BD Biosciences, Becton Dickinson), the world’s leading provider of flow cytometry solutions, is launching a new pretreatment device that washes cells without centrifugation. This has …
  • 2026-10-19 16:01:01
  • Kim Seung-kwon
Technology

Yang Jun-ho, CEO of BIOBIJOU Co., Ltd.: “Celivion to Enter the Japanese Market in the First Half of Next Year… Finalizing Terms with a Local Partner”

#BIOBIJOU Co., Ltd. is pushing to enter the Japanese market with its extracellular matrix (ECM) skin revitalizer, “Cellivion.” The company is currently finalizing contract terms with several local fir…
  • 2026-10-19 08:01:10
  • NA EUN-KYUNG
Technology

'Omliclo' Catches the Eye of the Next President of the Japanese Society of Allergy… Why? [WAC 2026]

Yasuhiro Gon, a professor in the Department of Respiratory Medicine at Nihon University School of Medicine, delivered a lecture titled “Recent Advances in Immunoglobulin E (IgE)-Targeted Therapy for S…
  • 2026-10-19 08:01:09
  • KIM SAE-MI
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English